Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report) shares shot up 11.1% during mid-day trading on Monday . The stock traded as high as $1.00 and last traded at $1.00. 317 shares traded hands during trading, a decline of 67% from the average session volume of 949 shares. The stock had previously closed at $0.90.
Mosaic ImmunoEngineering Stock Performance
The firm’s 50 day simple moving average is $0.92 and its 200-day simple moving average is $0.72. The company has a market cap of $7.24 million, a price-to-earnings ratio of -5.88 and a beta of 0.01.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Further Reading
- Five stocks we like better than Mosaic ImmunoEngineering
- What is MarketRank™? How to Use it
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What Investors Need to Know to Beat the Market
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
